Topical Minocycline Foam FXFM244

DRUG4 trials

Sponsors

Vyne Therapeutics Inc., Medical University of South Carolina

Conditions

Acne VulgarisConfluent and Reticulated Papillomatosis (CARP)ImpetigoRosacea

Early Phase 1

Topical Minocycline for CARP

Not yet recruitingNCT07462702

Medical University of South CarolinaConfluent and Reticulated Papillomatosis (CARP)

Start: 2026-09-15End: 2028-02-01Target: 35Updated: 2026-07-21

Phase 2

Study to Evaluate the Safety and Efficacy of Topical Minocycline FXFM244 in Rosacea Patients

TerminatedNCT01134991

Vyne Therapeutics Inc.Rosacea

Start: 2010-06-30Updated: 2015-08-26

Study to Evaluate the Safety and Efficacy of Topical Minocycline FXFM244 in Impetigo Patients

CompletedNCT01171326

Vyne Therapeutics Inc.Impetigo

Start: 2010-08-31End: 2012-04-30Updated: 2013-12-10

Clinical Study to Evaluate Tolerability and Safety of FXFM244 and to Monitor Clinical Effect in Acne Vulgaris Patients

CompletedNCT01362010

Vyne Therapeutics Inc.Acne Vulgaris

Start: 2012-01-31End: 2013-07-31Updated: 2013-08-15